© Gerd Bendas
Prof. Dr. Gerd Bendas
Zugehörigkeiten
- Pharmazeutisches Institut
- Mathematisch-Naturwissenschaftliche Fakultät
Forschungsschwerpunkte
- Cancer Cell Metastasis
- Chemoresistane
- Glycosaminoglycans
Cell biological approaches in oncological basic research, addressing phenomena of therapeutic resistance of cancer cells and molecular mechanistics of cancer cell metastasis in a hematological context
Ausgewählte Publikationen
Gockel LM, Heyes M, Li H, Al Nahain A, Gorzelanny C, Schlesinger M, Holdenrieder S, Li JP, Ferro V, Bendas G. (2021) Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin Mimetics. ACS Appl Mater Interfaces. 13(6):7080-7093
König P, Zhulenko R, Suparman E, Hoffmeister H, Bückreiß N, Ott I, Bendas G. (2023) A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis. Cancer Chemother Pharmacol. 92(1):57-69.
König P, Eichhorn JM, Suparman E, Bückreiß N, Cinatl J, Michaelis M, Bendas G. (2024) SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cells. Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167448.
© Gerd Bendas
Prof. Dr. Gerd Bendas